Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management
Aditya K. Gupta, Elizabeth A. Cooper, Tong Wang, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 12, pp. 2476-2483.e7
Closed Access | Times Cited: 22

Showing 22 citing articles:

Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents
Aditya K. Gupta, Boni E. Elewski, Warren S. Joseph, et al.
Mycoses (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 20
An update on antifungal resistance in dermatophytosis
Aditya K. Gupta, Avantika Mann, Shruthi Polla Ravi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 511-519
Closed Access | Times Cited: 10
Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: A prospective multicentric study
Daniela Kolarczyková, Pavlína Lysková, Michaela Švarcová, et al.
Mycoses (2024) Vol. 67, Iss. 2
Open Access | Times Cited: 9
Trichophyton indotineae and other terbinafine-resistant dermatophytes in North America
Shawn R. Lockhart, Dallas J. Smith, Jeremy A.W. Gold
Journal of Clinical Microbiology (2023) Vol. 61, Iss. 12
Open Access | Times Cited: 17
High Prevalence of Terbinafine Resistance Among Trichophyton mentagrophytes/T. interdigitale Species Complex, a Cross-Sectional Study from 2021 to 2022 in Northern Parts of Iran
Iman Haghani, Maryam Babaie, Akbar Hoseinnejad, et al.
Mycopathologia (2024) Vol. 189, Iss. 4
Closed Access | Times Cited: 7
Current and emerging issues in dermatophyte infections
Sarah Dellière, Arnaud Jabet, Alireza Abdolrasouli
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012258-e1012258
Open Access | Times Cited: 7
Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections
Aditya K. Gupta, Tong Wang, Avantika Mann, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 9, pp. 739-751
Open Access | Times Cited: 7
Single-Point Nail Sampling to Diagnose Onychomycosis Caused by Non-Dermatophyte Molds: Utility of Polymerase Chain Reaction (PCR) and Histopathology
Aditya K. Gupta, Elizabeth A. Cooper, Tong Wang, et al.
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 671-671
Open Access | Times Cited: 16
Isolation of Terbinafine-Resistant Trichophyton rubrum from Onychomycosis Patients Who Failed Treatment at an Academic Center in New York, United States
Jonathan K. Hwang, Wayne L. Bakotic, Jeremy A.W. Gold, et al.
Journal of Fungi (2023) Vol. 9, Iss. 7, pp. 710-710
Open Access | Times Cited: 12
Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae
Tsuyoshi Yamada, Mari Maeda, Hiroaki Nagai, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 11
Open Access | Times Cited: 12
Scratching the Surface: The Rise of Antifungal-Resistant Dermatophytes
Jeremy A.W. Gold, Shawn R. Lockhart
Clinical Microbiology Newsletter (2025)
Closed Access
Multidimensional insights into squalene epoxidase drug development: in vitro mechanisms, in silico modeling, and in vivo implications
Ahmed A. Allam, Hassan A. Rudayni, Noha Ahmed, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
Dermatophyte resistance – on the rise
Ivan Bristow, Lovleen Tina Joshi
Journal of Foot and Ankle Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Concerning rates of laboratory‐confirmed antifungal‐resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States
Kaitlin Benedict, Jeremy A.W. Gold, Carolynn Thomas Jones, et al.
Health Science Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 4
Autochthonous Trichophyton rubrum terbinafine resistance in France: Assessment of antifungal susceptibility tests
Alicia Moreno‐Sabater, Camille Cordier, Anne‐Cécile Normand, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1613-1615
Closed Access | Times Cited: 1
Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022
Aditya K. Gupta, Tong Wang, Anh N. Tran
Skin Appendage Disorders (2024), pp. 1-9
Open Access | Times Cited: 1
Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of Trichophyton spp.
Maria Siopi, Ioanna Efstathiou, Maiken Cavling Arendrup, et al.
Journal of Clinical Microbiology (2023) Vol. 62, Iss. 1
Open Access | Times Cited: 3
Antifungal Resistance on the Rise
Michel Monod, Gabriela Blanchard, Emmanuella Guenova
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 12, pp. 2332-2334
Open Access | Times Cited: 2
Potential emergence of terbinafine resistance by squalene epoxidase gene mutations: An 18‐month cohort study of onychomycosis patients in the United States
Aditya K. Gupta, Tong Wang, Shruthi Polla Ravi, et al.
Mycoses (2024) Vol. 67, Iss. 7
Open Access
Dermatophytoses, des problématiques émergentes
Arnaud Jabet, Sophie Brun, G. Crémer, et al.
Médecine et Maladies Infectieuses Formation (2024) Vol. 3, Iss. 3, pp. 119-127
Closed Access
Safety and efficacy of the swift microwave device in patients with mild‐to‐moderate onychomycosis: Protocol of an open‐label, randomized, dose‐finding pilot study
Aditya Gupta, Elizabeth A. Cooper, Tong Wang
Skin Health and Disease (2024) Vol. 4, Iss. 6
Open Access
Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis
Aditya K. Gupta, Avantika Mann, Shruthi Polla Ravi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 15, pp. 1983-1998
Closed Access
Page 1

Scroll to top